(Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ insulin pump users can now access full compatibility with ...

t:slim X2 pumps pre-loaded with the updated software will begin shipping to new customers in early January 2025. To check coverage and start the process of getting a Tandem insulin pump, please visit ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

A person wears the G7 (on the left arm) and t:slim X2 (on the waist). [Image courtesy of Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) announced today that t:slim X2 insulin pump users in ...

Cannulas can also bend, restricting the flow of insulin, and the pump can sometimes become disconnected from the tubing without the user noticing. The NHS only offers insulin pumps to those who ...

Most people diagnosed with diabetes use either an insulin pen or an insulin pump to regulate their blood sugar. An insulin pen is a needle diabetics inject into their skin when insulin levels are too ...

Insulin solutions must be placed in an infusion pump and piggybacked into the lower distal port of a maintenance i.v. line with a rate of at least 20 mL/hr. (Use 0.9% sodium chloride injection if ...

The insulin called Afrezza is created and manufactured by MannKind Corporation, and is used to improve glycemic control in adults with diabetes mellitus.“Afrezza is a rapid-acting insulin ...